Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
References 1 Rodriguez-RamirezSAl JurdiAKonvalinkaARiellaLV
The FDA's nutrition labeling guide emphasizes the importance of understanding ingredient lists
The early evidence says yes for the subset of patients with obesity-driven OSA
PMID 1728526
Gastrointestinal Effects The most commonly reported adverse effects are gastrointestinal in nature, including: Nausea and vomiting (affecting 20-40% of patients initially, varying by agent and dose) [8] Diarrhoea or constipation Abdominal discomfort and bloating Reduced appetite In elderly patients, persistent nausea and vomiting can lead to dehydration and electrolyte imbalances more rapidly than in younger adults
US$ 23.69
US$ 24.33
US$ 23.94
US$ 21.72
US$ 21.05
US$ 28.75
